Sino Biopharmaceutical Ltd (DE:SMZ1)
FRANKFURT:SMZ1
SMZ1 Analyst Ratings
Moderate Buy
2 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
SMZ1 Stock 12 Month Forecast
Average Price Target
€0.93
▲(45.92% Upside)
| Highest Price Target€0.98 | Average Price Target€0.93 | Lowest Price Target€0.87 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Bernstein
€0.88
Hold
37.72%
Upside
Reiterated
02/09/26
Unknown Analyst
DaiwaNot Ranked
Daiwa
€1.12
Buy
74.33%
Upside
Reiterated
11/12/25
Unknown Analyst
GF SecuritiesNot Ranked
GF Securities
€1.29
Buy
101.18%
Upside
Reiterated
10/14/25
CMB International Securities
€1.05
Buy
63.87%
Upside
Reiterated
10/13/25
UBS
€1.36
Buy
112.69%
Upside
Reiterated
09/29/25
Unknown Analyst
Guotai HaitongNot Ranked
Guotai Haitong
€1.12
Buy
74.33%
Upside
Reiterated
09/29/25
Unknown Analyst
Sinolink SecuritiesNot Ranked
Sinolink Securities
€1.26
Buy
96.13%
Upside
Reiterated
09/23/25
Macquarie
€0.78→€1.09
Buy
70.85%
Upside
Reiterated
09/08/25
Unknown Analyst
First Shanghai SecuritiesNot Ranked
First Shanghai Securities
€1.08
Buy
69.10%
Upside
Reiterated
08/27/25
Unknown Analyst
China Merchants SecuritiesNot Ranked
China Merchants Securities
€1.09
Buy
70.85%
Upside
Reiterated
08/22/25
Nomura
€0.86→€1.02
Buy
59.86%
Upside
Reiterated
08/19/25
Citi
€0.98→€1.2
Buy
88.28%
Upside
Reiterated
08/19/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bernstein
€0.88
Hold
37.72%
Upside
Reiterated
02/09/26
Unknown Analyst
DaiwaNot Ranked
Daiwa
€1.12
Buy
74.33%
Upside
Reiterated
11/12/25
Unknown Analyst
GF SecuritiesNot Ranked
GF Securities
€1.29
Buy
101.18%
Upside
Reiterated
10/14/25
CMB International Securities
€1.05
Buy
63.87%
Upside
Reiterated
10/13/25
UBS
€1.36
Buy
112.69%
Upside
Reiterated
09/29/25
Unknown Analyst
Guotai HaitongNot Ranked
Guotai Haitong
€1.12
Buy
74.33%
Upside
Reiterated
09/29/25
Unknown Analyst
Sinolink SecuritiesNot Ranked
Sinolink Securities
€1.26
Buy
96.13%
Upside
Reiterated
09/23/25
Macquarie
€0.78→€1.09
Buy
70.85%
Upside
Reiterated
09/08/25
Unknown Analyst
First Shanghai SecuritiesNot Ranked
First Shanghai Securities
€1.08
Buy
69.10%
Upside
Reiterated
08/27/25
Unknown Analyst
China Merchants SecuritiesNot Ranked
China Merchants Securities
€1.09
Buy
70.85%
Upside
Reiterated
08/22/25
Nomura
€0.86→€1.02
Buy
59.86%
Upside
Reiterated
08/19/25
Citi
€0.98→€1.2
Buy
88.28%
Upside
Reiterated
08/19/25
Best Analysts Covering Sino Biopharmaceutical
3 Months
xxx
Success Rate
3/3 ratings generated profit
Average Return
+46.57%
reiterated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +46.57% per trade.
1 Year
2 Years
xxx
Success Rate
2/3 ratings generated profit
Average Return
+22.23%
reiterated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +22.23% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
SMZ1 Analyst Recommendation Trends
Rating
Sep 25
Oct 25
Nov 25
Jan 26
Feb 26
Strong Buy
28
20
10
4
2
Buy
0
0
0
0
0
Hold
3
7
5
5
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
31
27
15
9
3
Each month's total comprises the sum of three months' worth of ratings.
SMZ1 Financial Forecast
SMZ1 Stock Forecast FAQ
What is DE:SMZ1’s average 12-month price target, according to analysts?
Based on analyst ratings, Sino Biopharmaceutical Ltd’s 12-month average price target is 0.93.
What is DE:SMZ1’s upside potential, based on the analysts’ average price target?
Sino Biopharmaceutical Ltd has 45.92% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Sino Biopharmaceutical Ltd a Buy, Sell or Hold?
Sino Biopharmaceutical Ltd has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 1 hold ratings and 0 sell ratings.
What is Sino Biopharmaceutical Ltd’s share price target?
The average share price target for Sino Biopharmaceutical Ltd is 0.93. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €0.98 ,and the lowest forecast is €0.87. The average share price target represents 45.92% Increase from the current price of €0.64.
The highest analyst share price target is €0.98 ,and the lowest forecast is €0.87. The average share price target represents 45.92% Increase from the current price of €0.64.
What do analysts say about Sino Biopharmaceutical Ltd?
Sino Biopharmaceutical Ltd’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of Sino Biopharmaceutical Ltd?
To buy shares of DE:SMZ1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.